Medbroadcast – Powered by MediResource
 Search

Go
 Browse alphabetically
ABCDEFGHIJKLMN
OPQRSTUVWXYZ
HEALTH TOPICS
Family & Child Health
Men's Health
Women's Health
Seniors' Health
Addiction
Allergy
Ankylosing Spondylitis
Arthritis (Rheumatoid)
Asthma
Atrial Fibrillation
Baby Health
Back Health
Bedwetting
Bladder (Overactive)
Brain Health
Cancer
Childhood Vaccinations
Cholesterol
Crohn's & Colitis
Cold and Flu
COPD NEW!
Cosmetic Procedures
Depression NEW!
Diabetes
Digestive Health
Ear Health
Eating Disorders
Eye Health
Flu (Seasonal)
Fertility
Fitness
Healthy Skin
Heart
High Blood Pressure
HPV
Hyperhidrosis
Incontinence
Infection
Kidney Health
Low Testosterone NEW!
Lung Health
Medications and your Health
Menopause
Mental Health
Multiple Sclerosis NEW!
Natural and Complementary Therapy
Nutrition
Obesity
Oral Care
Osteoarthritis of the Knee NEW!
Pain
Pregnancy
Psoriasis
Psoriatic Arthritis (PsA)
Seasonal Health
Sexual Health
Sleep Health
Stroke Risk Reduction
Smoking
Weight Management
Workplace Health
Yeast Infection
All health channels

STAY CONNECTED
RESOURCES
Ask an Expert
Clinical Trials
Find a Specialist
Health features
News
Tools


Condition Info Drug Info Tests and Procedures Natural Products Ask an Expert Support Groups Clinical Trials
Home Bookmark Page Send to a Friend Sante Chez Nous Subscribe
Health News > Psychosis Plus Pot a Bad Mix: Study
Select Health News Topic:

GO


Psychosis Plus Pot a Bad Mix: Study

Provided by
By Dennis Thompson
HealthDay Reporter

THURSDAY, March 3, 2016 (HealthDay News) -- People diagnosed with psychosis will probably have a longer, harder struggle to maintain their mental health if they're regular marijuana users, British researchers report.

And those who just experienced their first episode of psychotic illness are 50 percent more likely to need subsequent hospitalization for their condition if they use marijuana, according to findings published online March 3 in the journal BMJ Open.

They also spend longer periods in the hospital, averaging 35 more days in mental health wards during a five-year period than those with psychosis who don't use pot.

Finally, marijuana users don't seem to respond to anti-psychotic medications as well as non-users, said lead researcher Rashmi Patel, a clinical lecturer with the Department of Psychosis Studies at King's College London.

"We're not entirely sure why that is, but it's possible for whatever reason cannabis [marijuana] use makes it less likely that anti-psychotic treatment will work as well in people with psychotic disorders," Patel said.

Psychosis occurs when a person loses touch with reality. They may hallucinate, suffer from delusions, or experience disorganized thoughts and speech.

Psychosis is a symptom of a larger medical problem, which can include mental health disorders like schizophrenia and bipolar disorder. Alcohol, prescription drugs, dementia, brain diseases or stroke also can cause psychotic symptoms, according to the U.S. National Institutes of Health.

Previous research has linked marijuana use to increased risk of psychosis, but not much is known about the effect pot can have on someone with an established psychotic disorder, Patel said.

For this study, Patel and his colleagues reviewed the electronic health records of slightly more than 2,000 people treated for a first episode of psychosis between 2006 and 2013. They were treated at the South London and Maudsley NHS Foundation Trust, one of the largest providers of mental health services in Europe.

About 46 percent of the patients used marijuana. The researchers tracked all of the patients for up to five years to see if pot played a role in their ongoing mental health problems.

Pot users had an average of 1.8 hospital admissions up to five years after their first visit, compared to 1.2 admissions for non-users, the researchers found.

Marijuana users suffering psychosis were more likely than non-users to require compulsory detention in a hospital under England's Mental Health Act, and to require more days of treatment in a hospital.

Those using pot also were more likely to have more prescriptions for different antipsychotics, and to require treatment with clozapine -- a strong antipsychotic reserved for difficult-to-treat schizophrenia, the study authors said.

"We found a really quite significant association of cannabis use with poor outcomes," Patel said. "It's pretty clear there's a strong link, although we can't say what the mechanism is behind that."

No one knows much about how psychosis works in the brain, and so it's difficult to say why pot seems to make matters worse, said Dr. William Carpenter Jr., a professor of psychiatry and pharmacology at the University of Maryland School of Medicine.

It could be that marijuana is affecting the brain in some specific way that worsens psychosis, or the drug's normal action simply might help make a person's grasp on reality more tenuous, he said.

"It could be that anything that lowers our normal ability to tell what's real from unreal would increase our symptoms," Carpenter said.

Mitch Earleywine, an advisor to the marijuana legalization group NORML, said pot is one of any number of challenges to a hold on reality that should be avoided by people with psychosis.

"People with diagnosed psychotic disorders should stay away from cannabis. They should also stay away from alcohol, be careful about keeping their sleep cycle straight, avoid too much caffeine, carefully time their antihistamines, etc.," said Earleywine, a professor of psychology at the State University of New York at Albany.

Patel and Carpenter agreed that since this was an observational study, it also could be that the reported link is coincidental and marijuana does not directly cause these poor outcomes.

Nonetheless, the study does "raise valid concerns about potential negative effects," said Dr. Scott Krakower, assistant unit chief of psychiatry at Zucker Hillside Hospital in New Hyde Park, N.Y.

"Outpatient programs should actively incorporate screening tools for substance abuse in their practice, in an effort to recognize these warning signs earlier in high-risk individuals," he said.

More information

For more on psychosis, visit Yale University.




SOURCES: Rashmi Patel, Ph.D., clinical lecturer, Department of Psychosis, King's College London, England; William Carpenter Jr., M.D., professor of psychiatry and pharmacology, University of Maryland School of Medicine, Baltimore; Mitch Earleywine, Ph.D., professor of psychology, State University of New York at Albany; Scott Krakow, D.O., assistant unit chief of psychiatry, Zucker Hillside Hospital, New Hyde Park, N.Y.; March 3, 2016, BMJ Open, online

Last Updated: March 4, 2016

Copyright © 2016 HealthDay. All rights reserved.







 



Did you find what you were looking for on our website? Please let us know.






Hot Topics - Bedwetting, Depression, Flu (Seasonal), Healthy Skin, Incontinence, Multiple Sclerosis, Psoriasis, Stroke Risk Reduction

Condition and disease information is written and reviewed by the MedBroadcast Clinical Team.


The contents of this site are for informational purposes only and are meant to be discussed with your physician or other qualified health care professional before being acted on. Never disregard any advice given to you by your doctor or other qualified health care professional. Always seek the advice of a physician or other licensed health care professional regarding any questions you have about your medical condition(s) and treatment(s). This site is not a substitute for medical advice.
© 1996 - 2024 MediResource Inc. - MediResource reaches millions of Canadians each year.